Tuesday June 25, 2019

40% of Women with Asthma Have a Risk of Developing Chronic Lung Diseases

Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women than men.

0
//
Obesity, Asthma
They found that 10.2 per cent of people with asthma at the start of the study had become obese ten years on Flickr Commons

More than 4 in 10 individuals with asthma run the risk of developing chronic obstructive pulmonary disease (COPD), a group of lung diseases that block airflow and make it harder to breathe, says a new study involving around 4,000 women.

The researchers examined risk factors for developing asthma and COPD overlap syndrome, known as ACOS.

The findings, published in the journal Annals of the American Thoracic Society, showed that individual risk factors played a more significant role in the development of ACOS than exposure to fine particulate matter, a major air pollutant that because of its microscopic size penetrates deep into the lungs.

Women who had smoked more than the equivalent of a pack of cigarettes a day for five years, were much more likely to develop ACOS than those who smoked fewer cigarettes or never smoked.

However, ACOS did not affect only those who smoke as the researchers found that 38 per cent of the women who developed ACOS in the study had never smoked.

Lady With An Asthma Inhaler
The study also identified obesity, rural as significant risk factors for ACOS. VOA

The study also identified obesity, rural residence, lower education levels and unemployment as significant risk factors for ACOS.

The authors believe that these factors may result in suboptimal access to care, under-treatment of asthma and poor compliance to medications, all of which lead to more frequent asthma attacks.

These attacks in turn may lead to airway remodelling that increases the chances of developing ACOS.

Also Read: Lung Function Decline in Elderly Can be Delayed by Consuming Flavonoid

“Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women than men,” said Teresa To, Professor atUniversity of Toronto in Canada.

“We urgently need to identify and quantify risk factors associated with ACOS in women to improve their health and save lives,” To added. (IANS)

Next Story

High Costs Preventing People to Take Vital Asthma Medication

The results were published in the journal JACI : In Practice

0

Out-of-pocket costs are preventing many people from taking vital asthma medication, says a new study, calling for urgent interventions to promote discussions between patients and doctors about the cost of medicines to treat asthma.

The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which, if taken regularly, reduce the severity of the disease and the number of asthma-related deaths, said the researchers.

According to reports, at least one in every 10 asthma patient globally lives in India and the economic costs associated with asthma exceed those of TB and HIV/AIDS combined.

To reach this conclusion, researchers led by The George Institute for Global Health and the Woolcock Institute of Medical Research at UNSW Sydney, surveyed 1,400 people with asthma in Australia and found that half of the adults and one-third of the children in the study were either decreasing or skipping doses of asthma medicines to make them last longer.

“We know that preventer inhalers can be incredibly effective at controlling symptoms and preventing people from being hospitalised or even from dying of asthma, yet our study has found that out-of-pocket costs are preventing many from accessing medicines which can be life-saving,” said senior research fellow Tracey-Lea Laba of The George Institute.

asthama-in-kids
The study provides new insight that could help us predict and manage diseases like asthma – which are a significant public health burden. IANS

The study found that young male adults were the most likely to under-use asthma treatments.

This was compounded by doctors being largely unaware that out-of-pocket costs were a significant concern for many of their patients, or that some preventers had lower out-of-pocket costs for patients than others.

According to fellow study author Professor Helen Reddel of the Woolcock Institute at UNSW Sydney, asthma is a long-term disease and one where people really need to keep the inflammation under control by taking a preventative medicine and not just relying on short-term symptom relief from a blue inhaler.

Also Read- Researchers to Develop Wearable Devices to Help People with Mobility Issues Walk

“We need doctors to talk to their patients to stress that this Band-Aid approach does not work, and can leave them hospitalised or even worse as a result,” said Reddel.

The results were published in the journal JACI : In Practice. (IANS)